As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...
HHS underwent a sweeping restructuring this week, resulting in about 10,000 layoffs across various agencies. With critical programs for things like disease prevention and outbreak response already ...
All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA ...
About 90% of healthcare organizations are insecurely connected to the internet and running systems vulnerable to exploitation ...
Hospitals started 2025 with a stable financial performance driven by strong patient volumes, but rising costs for drugs, ...
Individual Coverage Health Reimbursement Arrangements (ICHRAs) are continuing to gain the interest of employers and investors. And Venteur’s $20 million Series A round announced on Tuesday is ...
Now that AI tools are everywhere, the question making headlines is whether businesses will see substantial returns from their AI investments. The answer for health plans is a definite yes.
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like ...
A month before 23andMe’s bankruptcy filing, CEO Anne Wojcicki had a fully financed proposal to take the genetic testing ...
Virtual and hybrid therapy companies are expanding rapidly amid persistently high demand levels for mental health services. On Tuesday, mental health care provider SonderMind participated in this ...
The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results